Rhys
Rhys Davies, Newbury GB
Patent application number | Description | Published |
---|---|---|
20110076985 | Data management in telecommunication networks - In a telecommunications network including one or more mobile terminals in communicable relation to a mobile network and a data network such that data from the mobile terminals is transmitted towards the data network via the mobile network, a method of directing data from the mobile terminals towards the data network includes: providing an alternative data route towards the data network which bypasses at least a portion of the mobile network; comparing the data from the mobile terminals with selection criteria; and using the result of the comparison to selectively redirecting at least a portion of the data generated by the mobile terminals onto the alternative data route. The alternative data route may be configured to bypass at least a portion of the core component of the mobile network, and data that is redirected is data which is not required to be processed by the bypassed core network component. | 03-31-2011 |
Rhys Jones, Gwynedd GB
Patent application number | Description | Published |
---|---|---|
20100305769 | METHOD AND APPARATUS FOR EXECUTING SECONDARY FUNCTIONS ON AN ELECTRICAL SWITCHGEAR DEVICE - This invention relates to a method and apparatus for executing secondary functions on an electrical switchgear device. In particular, the present invention relates to a method and apparatus which is implemented in the processing electronics of an electrical switchgear device which has a primary trip or protection function and also the capability to execute secondary functions or applications, such as over/undervoltage conditions and near fault warning levels and display. These secondary functions or applications being user configurable and are subject to processing availability and the constraints of the primary protection function. | 12-02-2010 |
Rhys Jones, Blackburn South AU
Patent application number | Description | Published |
---|---|---|
20150063903 | METHODS FOR TREATING AIRCRAFT STRUCTURES - The present invention relates to methods for repairing a structural weakness in an aircraft fuselage, or preventing the advancement of a structural weakness in an aircraft fuselage. Cold spray methods such as supersonic particle deposition have been shown to positively affect structural characteristics of sheet metal and lap joints as used in fuselage construction. | 03-05-2015 |
Rhys Mulryan, Corrandulla IE
Patent application number | Description | Published |
---|---|---|
20100202707 | Method and Component for Image Recognition - A method and system for image recognition in a collection of digital images includes training image classifiers and retrieving a sub-set of images from the collection. For each image in the collection, any regions within the image that correspond to a face are identified. For each face region and any associated peripheral region, feature vectors are determined for each of the image classifiers. The feature vectors are stored in association with data relating to the associated face region. At least one reference region including a face to be recognized is/are selected from an image. At least one classifier on which said retrieval is to be based is/are selected from the image classifiers. A respective feature vector for each selected classifier is determined for the reference region. The sub-set of images is retrieved from within the image collection in accordance with the distance between the feature vectors determined for the reference region and the feature vectors for face regions of the image collection. | 08-12-2010 |
Rhys Salter, Basel CH
Patent application number | Description | Published |
---|---|---|
20090299064 | METHODS AND INTERMEDIATES FOR THE PREPARATION OF OPTIONALLY RADIO-LABELED IMATINIB - The invention relates to new processes for the manufacture of N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}4-(3-pyridyl)-2-pyrimidine-amine (compound of formula I, | 12-03-2009 |
20120316338 | Methods and Intermediates for the Preparation of Optionally Radio-Labeled Imatinib - The invention relates to new processes for the manufacture of N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine (compound of formula I, | 12-13-2012 |
Rhys Whomsley, Hampshire GB
Patent application number | Description | Published |
---|---|---|
20120065152 | PRODRUGS OF GUANFACINE - Prodrugs of guanfacine, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for improving the pharmacokinetics of guanfacine or minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration are provided herein. | 03-15-2012 |
Rhys Whomsley, Alton GB
Rhys Whomsley, Basingstoke GB
Patent application number | Description | Published |
---|---|---|
20110065796 | PRODRUGS OF GUANFACINE - Prodrugs of guanfacine with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration, as well as improving the pharmacokinetics of guanfacine are provided herein. | 03-17-2011 |
20120178666 | PRODRUGS OF GUANFACINE - Prodrugs of guanfacine with amino acids or short peptides, pharmaceutical compositions containing such prodrugs and a method for providing therapeutic benefit in the treatment of ADHD/ODD (attention deficient hyperactivity disorder and oppositional defiance disorder) with guanfacine prodrugs are provided herein. Additionally, methods for minimizing or avoiding the adverse gastrointestinal side effects associated with guanfacine administration, as well as improving the pharmacokinetics of guanfacine are provided herein. | 07-12-2012 |